Within-Home Blood Pressure Variability on a Single Occasion Has Clinical Significance

Similar documents
Slide notes: References:

Ambulatory Blood Pressure Monitoring Clinical Practice Recommendations

ANTIHYPERTENSIVE DRUG THERAPY IN CONSIDERATION OF CIRCADIAN BLOOD PRESSURE VARIATION*

Morning Hypertension: A Pitfall of Current Hypertensive Management

Copyright Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.

Epidemiology/Population. Home Blood Pressure and Cardiovascular Outcomes in Patients During Antihypertensive Therapy

The Evolution To Treatment Of Hypertension With Advanced Formulation

Use and Interpretation of Home Blood Pressure Monitoring

Importance of Ambulatory Blood Pressure Monitoring in Adolescents

Blood Pressure Variability and Its Management in Hypertensive Patients

Cardiovascular Diseases in CKD

ORIGINAL ARTICLE AMBULATORY BLOOD PRESSURE IN OBESITY. Introduction. Patients and Methods

SUPPLEMENTARY DATA. Supplementary Table 1. Baseline Patient Characteristics

The applicability of home blood pressure measurement in clinical practice: A review of literature

ASSOCIATION OF SYSTEMIC INFLAMMATION WITH ARTERIAL STIFFNESS IN HYPERTENSION

The monthly ESH guide through publications

Response of Day-to-Day Home Blood Pressure Variability by Antihypertensive Drug Class After Transient Ischemic Attack or Nondisabling Stroke

This article will focus on the role of the following in BP management and their prognostic significance:

Validation of the SEJOY BP-1307 upper arm blood pressure monitor for home. blood pressure monitoring according to the European Society of Hypertension

Central blood pressure variability is increased in hypertensive patients with target organ damage

Association Between Residual Kidney Function and Visit-to-Visit Blood Pressure Variability in Peritoneal Dialysis Patients

Home blood pressure (BP) measurement has been reported

Assessing Blood Pressure for Clinical Research: Pearls & Pitfalls

Supplementary Table 1. Baseline Characteristics by Quintiles of Systolic and Diastolic Blood Pressures

Inhibitory Effects of Azelnidipine Tablets on Morning Hypertension

Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice

New Hypertension Guideline Recommendations for Adults July 7, :45-9:30am

Blood Pressure Monitoring in Chronic Kidney Disease

Home Blood Pressure Level, Blood Pressure Variability, Smoking, and Stroke Risk in Japanese Men: The Ohasama Study

Effect of Azilsartan on Day-to-Day Variability in Home Blood Pressure: A Prospective Multicenter Clinical Trial

The prognostic significance of blood pressure (BP) variability

Early Detection of Damaged Organ

Protocol. Automated Ambulatory Blood Pressure Monitoring for the Diagnosis of Hypertension in Patients with Elevated Office Blood Pressure

Ambulatory monitoring derived blood pressure variability and cardiovascular risk factors in elderly hypertensive patients

Blood Pressure. a change in any of these could cause a corresponding change in blood pressure

Dr Doris M. W Kinuthia

OBJECTIVES BACKGROUND METHODS RESULTS CONCLUSIONS

Atherosclerosis 219 (2011) Contents lists available at ScienceDirect. Atherosclerosis

and bias, which are known to be present in self-home and in professional office BP measurements taken using the auscultatory technique [7].

24-uur ambulante bloeddrukmeting versus thuisbloedrukmeting

Chapter 2 Home (Self) Monitoring of Blood Pressure

Original Article. Hypertens Res Vol.30 (2007) No.11 p

Recently, there is growing evidence that arterial

ORIGINAL INVESTIGATION. Prognosis of Isolated Systolic and Isolated Diastolic Hypertension as Assessed by Self-Measurement of Blood Pressure at Home

Significance of Cardiac Rehabilitation on Visit-to-Visit Variability of Blood Pressure in Patients With Cardiovascular Disease in a 12-Month Follow-Up

Nomogram of the Relation of Brachial-Ankle Pulse Wave Velocity with Blood Pressure

The accurate measurement of blood pressure

Evidence of Baroreflex Activation Therapy s Mechanism of Action

4/4/17 HYPERTENSION TARGETS: WHAT DO WE DO NOW? SET THE STAGE BP IN CLINICAL TRIALS?

Journal of the American College of Cardiology Vol. 46, No. 3, by the American College of Cardiology Foundation ISSN /05/$30.

The Relationship Between Ambulatory Arterial Stiffness Index and Blood Pressure Variability in Hypertensive Patients

5.2 Key priorities for implementation

Todd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM

Cardiorenal Syndrome

Effects of Kidney Disease on Cardiovascular Morbidity and Mortality

Association of Isolated Systolic, Isolated Diastolic, and Systolic-Diastolic Masked Hypertension With Carotid Artery Intima-Media Thickness

BLOOD PRESSURE VARIABILITY AND STROKE ADAM DE HAVENON, MD UNIVERSITY OF UTAH

Central Pressures and Prehypertension

Ambulatory arterial stiffness index as a predictor of cardiovascular events.

Hypertension is a major risk factor for stroke in developed

Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients

Association between arterial stiffness and cardiovascular risk factors in a pediatric population

Individual Study Table Referring to Part of Dossier: Volume: Page:

A Case of Vertebral Artery Dissection Associated with Morning Blood Pressure Surge

Choosing Study Outcomes that Reflect Cardiovascular Disease: From Biomarkers to Burden of Disease. Greg Wellenius Joel Kaufman

What s In the New Hypertension Guidelines?

Does Antihypertensive Drug Class Affect Day-to-Day Variability of Self-Measured Home Blood Pressure? The HOMED-BP Study

Cardiac Pathophysiology

Hypertension: What s new since JNC 7. Harold M. Szerlip, MD, FACP, FCCP, FASN, FNKF

Epidemiology/Population. Prognosis of White-Coat and Masked Hypertension

Catheter-Based Renal Sympathetic Denervation in the Management of Resistant Hypertension

BLOOD PRESSURE MEASUREMENT HOME BASED OR OFFICE BP MONITORING WHICH, HOW AND WHEN?

Trial to Reduce. Aranesp* Therapy. Cardiovascular Events with

LCZ696 A First-in-Class Angiotensin Receptor Neprilysin Inhibitor

Treatment Of Preserved Cardiac Function Heart Failure with an Aldosterone antagonist (TOPCAT) AHA Nov 18, 2014 Update on Randomized Trials

STATE OF THE ART BP ASSESSMENT

IN VIVO ASSESSMENT OF CENTRAL AND PERIPHERAL HEMODYNAMIC IMPACT OF THE C-PULSE SYSTEM

Effects of different antihypertensive drugs on blood pressure variability in patients with ischemic stroke

The Hypertension Clinic is a part of the Internal Medicine

KDIGO Controversies Conference on Blood Pressure in CKD

VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005

Special Lecture 11/08/2013. Hypertension Dr. HN Mayrovitz

Disclosure of Relationships

PULSE WAVE VELOCITY AS A NEW ASSESSMENT TOOL FOR ATHEROSCLEROSIS

Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes

METHODS. Shachaf Shiber-Ofer, MD; 1,2 Zipora Shohat, MSc; 3,2 Alon Grossman, MD 4,2

Blood Pressure Regulation. Faisal I. Mohammed, MD,PhD

Ambulatory Care Conference

Allopurinol reduces left ventricular hypertrophy and endothelial dysfunction in patients with chronic kidney disease

Hypertension Update 2016 AREEF ISHANI, MD MS CHIEF OF MEDICINE MINNEAPOLIS VA MEDICAL CENTER PROFESSOR OF MEDICINE UNIVERSITY OF MINNESOTA

Hypertension and Heart Disease. Weldon James, MD, Mercy Clinic Family Medicine, Union

UPDATES IN MANAGEMENT OF HF

Using the New Hypertension Guidelines

Difficult to Treat Hypertension

Clinical research. Introduction. * Corresponding author. Tel: þ ; fax: þ address:

When should you treat blood pressure in the young?

The morning pressor surge is an abrupt increase in blood

Nocturnal hypertension in diabetes: Potential target of sodium/ glucose cotransporter 2 (SGLT2) inhibition

Genetic factors. A number of genetic factors or interactions between genes play a major role in essential hypertension.

Home Blood Pressure Measurement A Systematic Review

Transcription:

Published online: May 12, 2016 2235 8676/16/0041 0038$39.50/0 Mini-Review Within-Home Blood Pressure Variability on a Single Occasion Has Seiichi Shibasaki a, b Satoshi Hoshide b Kazuomi Kario b a Department of General Internal Medicine, Saiseikai Yamaguchi General Hospital, Yamaguchi, and b Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University, Shimotsuke, Japan Key Words Blood pressure variability Home blood pressure Multiple measurement on a single occasion Abstract There is growing evidence that diversely defined blood pressure variability (BPV) is an independent predictor of hypertensive target organ damage (TOD) and cardiovascular events. Several mechanisms have been speculated to underlie episodes of increased BPV, including the impairment of autonomic or hormonal regulation, renal dysfunction, and increased arterial stiffness. Within-home BPV, defined as differences in BP values obtained on a single occasion at home, could have prognostic significance for hypertensive TOD. It is typically thought that BP values are decreased with repeated measurements on a single occasion at home, but in the present subanalysis of 4,149 J-HOP (Japan Morning Surge-Home Blood Pressure) study patients, approximately 20% of the patients home BP values were increased or unchanged by repeated measurements on a single occasion. In addition, those patients were likely to have hypertensive TOD. Thus, home BP measurement should be taken twice or more to detect the increase trend in home BP, which has been defined as within-home BPV. Relationship between Blood Pressure Variability and Hypertensive Target Organ Damage and Prognosis There is growing evidence that diversely defined blood pressure variability (BPV) is an independent predictor of hypertensive target organ damage (TOD) and cardiovascular events [1 3]. In particular, long-term BPV was defined as visit-to-visit BP fluctuation at a clinic, Kazuomi Kario Division of Cardiovascular Medicine, Department of Medicine Jichi Medical University, 3311-1 Yakushiji Shimotsuke, Tochigi 329-0498 (Japan) E-Mail kkario @ jichi.ac.jp

39 which was a strong predictor of stroke in systolic BP (SBP), independent of the mean SBP value [4]. Mid-term BPV has been defined as day-by-day BP fluctuation in home BP (HBP) values, and it has been also shown to contribute to the risks of total, cardiovascular, and stroke mortality [5]. Short-term BPV is defined as reading-to-reading BP fluctuation in ambulatory BP measurements, which has also been demonstrated to be a significant and independent predictor of mortality and of cardiovascular and stroke events [6]. Several mechanisms have been suggested to underlie episodes of increased BPV, including the impairment of autonomic or hormonal regulation, renal dysfunction, and increased arterial stiffness [7]. Each of the above-described types of BPV has been examined in light of the clinical implications of multiple BP measurements and clinical applications. Even for multiple BP measurements obtained on one occasion, the BPV was reported to be a prognostic marker of cardiovascular events [1], in a phenomenon named within-visit BPV in clinic BP measurement. Conversely, some studies showed no association of within-visit BPV with outcomes [8]. In accordance with this trend, within-home BPV (defined as differences in BP values obtained on a single occasion at home) could have prognostic significance for hypertensive TOD. However, our previous guideline for HBP measurement recommended taking one BP measurement twice a day, in the morning and evening. We revised this recommendation to an average of two measurements on each occasion (morning and evening) in accordance with the European guideline [9]. Within-home BPV has not been studied sufficiently. In the present study, we conducted a subanalysis of the Japan Morning Surge-Home Blood Pressure (J-HOP) study to determine whether the differences in BP values measured on a single occasion at home can be used to predict hypertensive TOD, and our results demonstrated that an increased trend in HBP values obtained on a single occasion is associated with hypertensive TOD [10]. Brief Methods and Protocol of the J-HOP Study The J-HOP study enrolled 4,149 ambulant patients. HBP values were measured by the patients, using a validated upper arm cuff oscillometric BP device according to the Japanese Society of Hypertension 2004 guidelines [11]. This device automatically takes three measurements at 15-second intervals after a measurement button is pressed once. For the measurement of HBP, the patients were instructed to take their BP in a sitting position after at least 2 min of rest, and to measure their morning HBP and evening HBP in a sitting position each day for a 2-week period. All data in the HBP measurement device were downloaded to a computer and sent to the study control center. The single-occasion difference in HBP values was defined as the difference between the first HBP value minus the average of the second and third HBP values. To avoid using an arbitrary definition, we defined the median quintile group (third quintile) as the comparator group. We hypothesized that the differences in BP values measured on a single occasion at home can be used to predict hypertensive TOD, and we contend that our findings provide evidence for recommending multiple BP measurements on a single occasion at home. Results of Our Subanalysis of the J-HOP Study The first BP and the mean BP values of twice measurements have been shown in table 1. We divided all 4,149 patients of the J-HOP into quintile groups according to the differences between their first home SBP values and the average of the second and third home SBP values. Compared to the median quintile group, the patients in the first quintile group (i.e., those with

40 Table 1. Single versus twice BP measurement(s) for within-home BPV First BP value, mm Hg 136.2 ± 15 Mean BP value of twice measuremen ts, mm Hg 135.5 ± 14 p value <0.001 elevated second and third home SBP values compared to the first value) were significantly older, significantly more likely to be male, and had significantly lower body mass index values, a significantly higher percentage of alpha-blocker medication use, a significantly higher smoking rate, a significantly higher rate of diabetes mellitus, and a significantly higher average of the second and third home SBP values. Compared to the quintile median, the fifth quintile patients (i.e., those with the greatest differences between their first home SBP values and the average of the second and third home SBP values) were significantly older, significantly more likely to be female, and had a significantly higher rate of hypertension, a significantly lower smoking rate, and significantly higher average home SBP. Compared to the quintile median, the fifth quintile patients (i.e., those with the greatest differences between their first home SBP values and the average of the second and third home SBP values) were significantly older, significantly more likely to be female, and had a significantly higher rate of hypertension, a significantly lower rate of smoking, and significantly higher average home SBP values. Compared to the quintile median values, the TODs of the first quintile patients were significantly higher brain natriuretic peptide (BNP) levels, significantly higher NT-pro BNP levels, significantly higher brachial-ankle pulse wave velocity values, and significantly lower estimated glomerular filtration rate (egfr) values. There were no significant differences among the quintile groups based on the difference between the first and the average of the second and third home SBP values in the left ventricular mass index, the urinary albumin creatinine ratio, the level of high-sensitivity cardiac troponin, or the intima-media thickness. On the other hand, compared to the quintile median values, the TODs of the first quintile patients were significantly higher NT-pro BNP. There were no significant differences among the quintile groups according to the difference between the first and the average of the second and third home SBP values in the other TODs. We performed a UNIANOVA to test these TOD indicators independently of their association with the difference between the first and the average of the second and third home SBP values. Significantly different factors among quintile groups were selected as covariates for the confounding effects in the UNIANOVA, and the Bonferroni test was used for the multiple pairwise comparisons compared with the median quintile group. In the post hoc test, compared to the quintile median, the first quintile patients had independently and significantly higher BNP, higher NT-pro BNP, and lower egfr values. Changes in BP Values Obtained on a Single Occasion Approximately 20% of the patients home SBPs were not changed or were increased by the repeated measurements on a single occasion. In addition, 20% of the patients home SBP values were decreased by >5 mm Hg with repeated measurement. Several studies have shown that SBP has a tendency to decrease with repeated measurement after the first reading; the reported differences between the first and second measurements were the averaged values 2.3 [12] and 3.5 mm Hg [13]. These repeated-measurement BP differences obtained on a single occasion have been observed for 7 [14] and 6 days [15]. However, these results were calculated from mass data. When the focus was on individual subjects SBP changes over repeated (triplicate) measurements, decreased SBP was seen in 60% of the

41 Normal endothelial function Nitric oxide Sleeve compression Nitric oxide Endothelial dysfunction TOD Central nervous system Sympathetic nerve hyperactivity Feeling nervous about measuring HBP Astonishment upon seeing one s own first BP value Decrease trend in BP on a single occasion Increase trend in BP on a single occasion Fig. 1. Mechanisms and relations underlying the increased BP trend on a single occasion of HBP measurements, sympathetic nerve hyperactivity, and hypertensive TOD. The relationship between the increased BP trend on a single occasion of HBP measurement and endothelial dysfunction is also shown. subjects, increased SBP was observed in 30%, and no change was seen in 10% [16]. Thus, it is important to keep in mind that with repeated measurements, many individuals will show increased HBP. Mechanisms by Which the Increase in the Second and Third Values Would Result in Adverse Outcomes Several studies have noted that sympathetic nerve hyperactivity was associated with deteriorated BNP [17] and chronic kidney disease [18]. Easy sympathetic nerve hyperactivation due to an individual s astonishment upon seeing his or her own first BP values causes an elevation of SBP in the second and third measurements on a single occasion. Thus, the patients who easily develop sympathetic nerve hyperactivation may be likely to have deteriorated hypertensive TOD values: i.e., increased BNP, increased NT-pro BNP, and decreased egfr ( fig. 1 ). It has been speculated that peripheral vasodilatation could be induced by nitric oxide, which was activated with compression sleeves in patients with normal endothelial function [19]. Therefore, the BP would be unlikely to decrease in patients with endothelial dysfunction, who are likely to be associated with TOD ( fig. 1 ). Clinical Applications of Our Findings The methods and vision for applying our present findings in clinical settings are as follows. (1) It is typically thought that BP values decrease with repeated measurement on a single occasion at home, but approximately 20% of the J-HOP patients HBP values were increased or unchanged by repeated measurements on a single occasion. (2) It is especially important to check the increase trend in HBP by multiple measurements on a single occasion for patients who are older, male, with a lower body mass index, taking an alpha-blocker, smokers, and those with diabetes. (3) Patients who show an increase trend in HBP should be examined for hypertensive TOD, even if their HBP values are not very high, and (4) HBP should be measured twice or more to detect the increase trend in HBP (i.e., within-home BPV).

42 BP has been thought to decrease with repeated measurement on a single occasion at home, but in practice, this trend was observed in a clinical trial calculated from mass data. It is noteworthy that 1 of 5 J-HOP patients HBPs was increased or not changed by repeated measurements on a single occasion. In addition, hypertensive TOD could be predicted by multiple measurements on a single occasion, whereas the hypertensive TOD could not be predicted by only a single measurement. Thus, multiple measurements should be employed on a single occasion for HBP measurement, and it is important to evaluate not only the absolute BP values but also the within-home BPV. References 1 Rothwell PM, Howard SC, Dolan E, et al: Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol 2010; 9: 469 480. 2 Wei FF, Li Y, Zhang L, et al: Beat-to-beat, reading-to-reading, and day-to-day blood pressure variability in relation to organ damage in untreated Chinese. Hypertension 2014; 63: 790 796. 3 Kikuya M, Hozawa A, Ohokubo T, et al: Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension 2000; 36: 901 906. 4 Rothwell PM, Howard SC, Dolan E, et al: Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010; 375: 895 905. 5 Kikuya M, Ohkubo T, Metoki H, et al: Day-by-day variability of blood pressure and heart rate at home as a novel predictor of prognosis: the Ohasama study. Hypertension 2008; 52: 1045 1050. 6 Hansen TW, Thijs L, Li Y, et al: International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes Investigators. Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8,938 subjects from 11 populations. Hypertension 2010; 55: 1049 1057. 7 Parati G, Faini A, Valentini M: Blood pressure variability: its measurement and significance in hypertension. Curr Hypertens Rep 2006; 8: 199 204. 8 Muntner P, Levitan EB, Reynolds K, et al: Within-visit variability of blood pressure and all-cause and cardiovascular mortality among US adults. J Clin Hypertens 2012; 14: 165 171. 9 Parati G, Stergiou GS, Asmar R, et al: European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens 2010; 24: 779 785. 10 Shibasaki S, Hoshide S, Eguchi K, et al; Japan Morning Surge-Home Blood Pressure (J-HOP) Study Group: Increase trend in home blood pressure on a single occasion is associated with B-type natriuretic peptide and the estimated glomerular filtration rate. Am J Hypertens 2015; 28: 1098 1105. 11 Imai Y, Otsuka K, Kawano Y, et al; Japanese Society of Hypertension: Japanese Society of Hypertension (JSH) guidelines for self-monitoring of blood pressure at home. Hypertens Res 2003; 26: 771 782. 12 Johansson JK, Niiranen TJ, Puukka PJ, et al: Optimal schedule for home blood pressure monitoring based on a clinical approach. J Hypertens 2010; 28: 259 264. 13 Stergiou GS, Nasothimiou EG, Kalogeropoulos PG, et al: The optimal home blood pressure monitoring schedule based on the Didima outcome study. J Hum Hypertens 2010; 24: 158 164. 14 Verberk WJ, Kroon AA, Kessels AG, et al: The optimal scheme of self blood pressure measurement as determined from ambulatory blood pressure recordings. J Hypertens 2006; 24: 1541 1548. 15 Stergiou GS, Skeva II, Zourbaki AS, et al: Self-monitoring of blood pressure at home: how many measurements are needed? J Hypertens 1998; 16: 725 731. 16 Kawabe H, Saito I, Saruta T: Influence of repeated measurement on one occasion, on successive days, and on workdays on home blood pressure values. Clin Exp Hypertens 2005; 27: 215 222. 17 Sakata K, Iida K, Mochiduki N, et al: Brain natriuretic peptide (BNP) level is closely related to the extent of left ventricular sympathetic overactivity in chronic ischemic heart failure. Intern Med 2009; 48: 393 400. 18 Neumann J, Ligtenberg G, Klein IH, et al: Sympathetic hyperactivity in hypertensive chronic kidney disease patients is reduced during standard treatment. Hypertension 2007; 49: 506 510. 19 Sinoway LI, Hendrickson C, Davidson WR Jr, et al: Characteristics of flow-mediated brachial artery vasodilation in human subjects. Circ Res 1989; 64: 32 42.